How long can a patient with chronic myeloid leukemia live?

Jun 01, 2022 Source: Cainiu Health
Dr. Li Man
Introduction
The average life expectancy for patients with chronic myeloid leukemia (CML) is approximately 10 years. Although the disease progresses slowly, it can become life-threatening at any time—particularly during infections. In such cases, the most critical treatment is actively pursuing HLA-matched donor identification for hematopoietic stem cell transplantation. Following imatinib therapy, the median survival of chronic-phase CML patients is expected to extend to 20 years. Chronic myeloid leukemia may cause fatigue in affected individuals.

A slowly progressive malignant blood disorder. The cause remains unknown, but the patient has been diagnosed with chronic leukemia—a condition widely regarded as difficult to treat. So, how long can a person with chronic myeloid leukemia (CML) live?

How long can a person with chronic myeloid leukemia live?

The average life expectancy for individuals with CML is approximately 10 years. Although disease progression is typically slow, it can become life-threatening at any time—especially in the event of infection. In such cases, the most critical therapeutic intervention is actively pursuing HLA-matched donor identification for hematopoietic stem cell transplantation (HSCT). Following treatment with imatinib, the median overall survival for chronic-phase CML patients is projected to extend to about 20 years.

Chronic myeloid leukemia may cause fatigue, loss of appetite, unintended weight loss, night sweats, and general physical wasting. Some patients develop splenomegaly—an abnormal enlargement of the spleen. As the disease advances—even into the accelerated phase—patients may experience widespread bone pain, persistent fever, epistaxis (nosebleeds), oral bleeding, or cutaneous hemorrhages. Early diagnosis and prompt initiation of appropriate treatment are strongly recommended to detect the disease early and control its progression. Additionally, patients should take precautions against cold exposure, maintain adequate warmth, ensure optimal nutritional intake, and strengthen their immune defenses. It is advisable for patients to seek evaluation and management promptly at a hospital hematology department.

Patients with chronic myeloid leukemia should consume a diet rich in high-quality protein, vitamins, calories, and essential nutrients—and easily digestible. During chemotherapy, patients are encouraged to increase fluid intake, especially water. We hope this information proves helpful to you!